Kia Carens Clavis EV vs Hyundai Creta Electric: Which Korean electric vehicle will you pick
Kia has rolled out the Carens Clavis EV, India's first mainstream electric MPV, with an aggressive starting price of ₹ 17.99 lakh (ex-showroom) and a claimed range of up to 490 km. It lands directly in the path of the Hyundai Creta Electric, which shares its E-GMP-derived platform and similar mechanicals but brings a more compact SUV form factor to the table. While both vehicles are targeted at the fast-growing premium electric segment under ₹ 25 lakh, they cater to very different needs.
So which EV should you choose — the family-friendly Carens Clavis EV or the stylish Creta Electric? Here's how they stack up on design, features, performance, and pricing. Kia Carens Clavis EV vs Hyundai Creta Electric: Design
The Kia Carens Clavis EV blends its MPV heritage with distinctive EV styling elements. It stands tall with a more upright stance and features a closed-off front grille, Star Map LED DRLs, and 17-inch aero-optimised alloy wheels. The rear design has full-width lighting and a high-stop lamp, providing it a bit of a futuristic but practical appearance. The extensive glass area, raised body proportions, and roof rails focus on practicality and room for families.
Also Read : Kia Carens Clavis EV launched with 490 km range, prices start at ₹ 17.99 lakh
Comparison, on the other hand, sees the Hyundai Creta Electric embracing the traditional shape of the ICE Creta but incorporating some EV-inspired elements. The front grille is closed off, alloy wheels have been optimized for aerodynamic prowess, and blue highlights subtly suggest its electric powertrain. It appears more diminutive, more premium, and more urban-friendly than the Carens, which has an inclination towards practicality. Kia Carens Clavis EV vs Hyundai Creta Electric: Features
Both the Carens Clavis EV and the Hyundai Creta Electric feature a comprehensive features list, such as a 10.25-inch touchscreen infotainment system, digital instrument cluster, wireless charging, dual-zone automatic climate control, ventilated front seats, and 360-degree camera. They also have connected car technology and advanced driver assistance systems (ADAS) like lane-keep assist, forward collision warning, and adaptive cruise control.
Where the Carens EV differentiates itself is in the cabin flexibility and extra layers of technology. It offers 64-colour ambient lighting, boss-mode HVAC controls, paddle-based regenerative braking, a shift-by-wire rotary drive selector, and even a 25-litre frunk (front trunk) for additional storage. The cabin has been designed to suit family road trips and long drives.
Meanwhile, the Creta Electric brings in segment-first touches like a powered tailgate and memory seats, enhancing convenience in an urban setting. The five-seater layout and compact footprint make it ideal for city driving while retaining a premium feel. Also watch: Hyundai Creta EV review | India's best-selling SUV goes electric | Range, Battery, Price expectation Kia Carens Clavis EV vs Hyundai Creta Electric: Specifications
Beneath the skin, both EVs are identical with the same 42 kWh and 51.4 kWh battery pack options and a front-mounted electric motor offering a maximum of 160 PS and 240 Nm torque. They also have the same front-wheel-drive system and come with a variety of driving modes. The range figures only marginally tip in favour of the Carens. Kia is quoted for a maximum of 490 km (ARAI approved) by the long-range variant, while the Creta Electric has a quoted maximum of 473 km. Even the short-range version of the Carens claims around 404 km, which edges past the Creta's 390 km.
In terms of charging, the Carens Clavis EV supports faster DC charging, with 10 to 80 percent charging in just 35 minutes, compared to the Creta Electric's 50-minute timeline. Importantly, the Carens offers three-row seating with a seven-seater configuration, while the Creta Electric continues as a strict five-seater, making the former more appealing for larger families or intercity commuters. Kia Carens Clavis EV vs Hyundai Creta Electric: Price
Both EVs start at ₹ 17.99 lakh (ex-showroom) for their entry-level variants, placing them in direct competition. However, the Carens Clavis EV goes up to ₹ 24.49 lakh for its top-end HTX+ long-range trim, while the Creta Electric is expected to be priced slightly lower at the top end, around ₹ 23.50 lakh, although Hyundai is yet to reveal the final pricing for all trims.
What tips the scales slightly in Kia's favour is the value proposition. For a similar price, it offers more seating, better range, and additional convenience features that may resonate better with families or long-distance users.
Check out Upcoming EV Cars in India, Upcoming EV Bikes in India.
First Published Date: 16 Jul 2025, 11:08 am IST
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
an hour ago
- New Indian Express
E-rickshaws banned from ferrying school children in Bhopal from Monday
BHOPAL: Use of E-rickshaws to ferry school children has been banned due to safety reasons in Madhya Pradesh capital Bhopal from Monday. The Bhopal district collector Kaushlendra Vikram Singh has ordered the ban of E-rickshaws for transport of school children, considering the vehicle not safe for children. The decision was taken based on the discussions held at the recent meeting for streamlining and ensuring safe road traffic in the MP capital. The meeting chaired on Friday by the Bhopal MP and ex-mayor Alok Sharma and attended among others by the higher ups of the district administration and the police commissionerate, had found battery powered E-rickshaws unsafe for school children. After the meeting, the district collector issued the order, banning the use of E-rickshaws to ferry school children. The order will come into effect from Monday and the school education department with the help of district administration and police will ensure that it's duly followed. According to Bhopal police sources, around 12,500 E-rickshaws are currently registered in Bhopal. Though these battery powered vehicles aren't attached with schools officially, many parents are using them to send their wards to school. 'Fortunately, there hasn't been any accident with school children travelling by E-rickshaw so far, but keeping in mind it's lightweight amid the fast traffic in the city, safety is a big concern for school children going to school by the battery powered vehicle,' a Bhopal police officer told the TNIE. 'In some cases, it has also been found that untrained and teenaged drivers are driving the E-rickshaws and that too at high speed, which makes the vehicle more unsafe, particularly when being used to ferry children,' sources added.
News18
9 hours ago
- News18
Dr Reddys gets seven observations from USFDA for Andhra plant
New Delhi, Jul 20 (PTI) Dr Reddy's Laboratories has received a Form 483 with seven observations from the US health regulator for its Srikakulam-based plant in Andhra Pradesh, according to a regulatory filing. The US Food and Drug Administration (USFDA) conducted the GMP and a Pre-Approval Inspection (PAI) at the formulations manufacturing facility from July 10 to 18, 2025, the Hyderabad-based drug major said in the filing. 'We have been issued a Form 483 with seven observations, which we will address within the stipulated timeline," it added. As per the USFDA, Form 483 is issued to a firm's management at the conclusion of an inspection when the investigator has observed any conditions that may constitute violations of the Food, Drug and Cosmetic (FD&C) Act and related Acts. PTI MSS BAL BAL Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
10 hours ago
- Time of India
Dr Reddy's gets seven observations from USFDA for Andhra plant
Dr Reddy's Laboratories has received a Form 483 with seven observations from the US health regulator for its Srikakulam-based plant in Andhra Pradesh , according to a regulatory filing. The US Food and Drug Administration ( USFDA ) conducted the GMP and a Pre-Approval Inspection (PAI) at the formulations manufacturing facility from July 10 to 18, 2025, the Hyderabad-based drug major said in the filing. Explore courses from Top Institutes in Select a Course Category Management healthcare Degree Leadership Project Management Others Data Science Design Thinking CXO Cybersecurity Data Science MCA PGDM MBA Operations Management Data Analytics Digital Marketing Product Management others Public Policy Technology Healthcare Finance Artificial Intelligence Skills you'll gain: Duration: 11 Months IIM Kozhikode CERT-IIMK General Management Programme India Starts on undefined Get Details Skills you'll gain: Duration: 9 Months IIM Calcutta CERT-IIMC APSPM India Starts on undefined Get Details Skills you'll gain: Duration: 10 Months IIM Kozhikode CERT-IIMK GMPBE India Starts on undefined Get Details "We have been issued a Form 483 with seven observations, which we will address within the stipulated timeline," it added. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 15 Most Beautiful Female Athletes in the World Click Here Undo As per the USFDA, Form 483 is issued to a firm's management at the conclusion of an inspection when the investigator has observed any conditions that may constitute violations of the Food, Drug and Cosmetic (FD&C) Act and related Acts.
